Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00532389
Recruitment Status : Completed
First Posted : September 20, 2007
Last Update Posted : November 3, 2014
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : October 2013